{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:09:57Z","timestamp":1792091397573,"version":"4.4.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10787-025-01890-z","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:46:05Z","timestamp":1755020765000},"page":"5037-5047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The renin\u2013angiotensin system (RAS) and arthritic diseases: therapeutic potential for RAS inhibitors"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6141-0519","authenticated-orcid":false,"given":"Yasser H.","family":"Habib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mennatallah A.","family":"Gowayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"1890_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biopha.2017.05.062","volume":"92","author":"HM Abuohashish","year":"2017","unstructured":"Abuohashish HM et al (2017) ACE-2\/Ang1\u20137\/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats. Biomed Pharmacother 92:58\u201368. https:\/\/doi.org\/10.1016\/j.biopha.2017.05.062","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1890_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/taap.2000.8985","volume":"168","author":"AM Agha","year":"2000","unstructured":"Agha AM, Mansour M (2000) Effects of captopril on interleukin-6, leukotriene B(4), and oxidative stress markers in serum and inflammatory exudate of arthritic rats: evidence of antiinflammatory activity. Toxicol Appl Pharmacol 168(2):123\u2013130. https:\/\/doi.org\/10.1006\/taap.2000.8985","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"1890_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1549-8719.2001.tb00158.x","volume":"8","author":"SL Amaral","year":"2001","unstructured":"Amaral SL et al (2001) Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 8(1):57\u201367","journal-title":"Microcirculation"},{"issue":"6","key":"1890_CR4","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1097\/PR9.0000000000000696","volume":"3","author":"P Arsenault","year":"2018","unstructured":"Arsenault P et al (2018) NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain. Pain Rep 3(6):e696. https:\/\/doi.org\/10.1097\/PR9.0000000000000696","journal-title":"Pain Rep"},{"issue":"9","key":"1890_CR5","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jsps.2020.07.011","volume":"28","author":"AA Azouz","year":"2020","unstructured":"Azouz AA, Saleh E, Abo-Saif AA (2020) Aliskiren, tadalafil, and cinnamaldehyde alleviate joint destruction biomarkers; MMP-3 and RANKL; in complete Freund\u2019s adjuvant arthritis model: downregulation of IL-6\/JAK2\/STAT3 signaling pathway. Saudi Pharm J 28(9):1101\u20131111. https:\/\/doi.org\/10.1016\/j.jsps.2020.07.011","journal-title":"Saudi Pharm J"},{"key":"1890_CR110","doi-asserted-by":"publisher","first-page":"9810","DOI":"10.1038\/s41598-022-13750-9","volume":"12","author":"L Bai","year":"2022","unstructured":"Bai L, Zhang Y, Wang P et al (2022) Improved diagnosis of rheumatoid arthritis using an artificial neural network. Sci Rep 12:9810. https:\/\/doi.org\/10.1038\/s41598-022-13750-9","journal-title":"Sci Rep"},{"issue":"7","key":"1890_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/emmm.201000080","volume":"2","author":"A Benigni","year":"2010","unstructured":"Benigni A, Cassis P, Remuzzi G (2010) Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2(7):247\u2013257. https:\/\/doi.org\/10.1002\/emmm.201000080","journal-title":"EMBO Mol Med"},{"issue":"8","key":"1890_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/rheumatology\/31.8.509","volume":"31","author":"KD Bhoola","year":"1992","unstructured":"Bhoola KD, Elson CJ, Dieppe PA (1992) Kinins\u2013key mediators in inflammatory arthritis? Br J Rheumatol 31(8):509\u2013518. https:\/\/doi.org\/10.1093\/rheumatology\/31.8.509","journal-title":"Br J Rheumatol"},{"issue":"5","key":"1890_CR8","first-page":"603","volume":"17","author":"HA Bird","year":"1990","unstructured":"Bird HA et al (1990) A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis. J Rheumatol 17(5):603\u2013608","journal-title":"J Rheumatol"},{"issue":"1","key":"1890_CR9","doi-asserted-by":"publisher","first-page":"e2022009","DOI":"10.23749\/mdl.v113i1.12622","volume":"113","author":"P Boffetta","year":"2022","unstructured":"Boffetta P, Collatuzzo G (2022) Application of P4 (predictive, preventive, personalized, participatory) approach to occupational medicine. Med Lav 113(1):e2022009. https:\/\/doi.org\/10.23749\/mdl.v113i1.12622","journal-title":"Med Lav"},{"issue":"1","key":"1890_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/14397595.2020.1740418","volume":"31","author":"NFT Braz","year":"2021","unstructured":"Braz NFT et al (2021) Renin-angiotensin system molecules are associated with subclinical atherosclerosis and disease activity in rheumatoid arthritis. Mod Rheumatol 31(1):119\u2013126. https:\/\/doi.org\/10.1080\/14397595.2020.1740418","journal-title":"Mod Rheumatol"},{"issue":"8","key":"1890_CR11","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/rheumatology\/keu018","volume":"53","author":"O Bruy\u00e8re","year":"2014","unstructured":"Bruy\u00e8re O et al (2014) Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis. Rheumatology (Oxford) 53(8):1457\u20131464. https:\/\/doi.org\/10.1093\/rheumatology\/keu018","journal-title":"Rheumatology (Oxford)"},{"issue":"9204","key":"1890_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/s0140-6736(99)10365-9","volume":"355","author":"M Burnier","year":"2000","unstructured":"Burnier M, Brunner HR (2000) Angiotensin II receptor antagonists. Lancet 355(9204):637\u2013645. https:\/\/doi.org\/10.1016\/s0140-6736(99)10365-9","journal-title":"Lancet"},{"issue":"11","key":"1890_CR13","first-page":"1605","volume":"36","author":"G Caspritz","year":"1986","unstructured":"Caspritz G, Alpermann HG, Schleyerbach R (1986) Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat. Arzneimittelforschung 36(11):1605\u20131608","journal-title":"Arzneimittelforschung"},{"key":"1890_CR14","doi-asserted-by":"publisher","first-page":"755230","DOI":"10.3389\/fphar.2021.755230","volume":"12","author":"T Chen","year":"2021","unstructured":"Chen T et al (2021) Update on novel non-operative treatment for osteoarthritis: current status and future trends. Front Pharmacol 12:755230. https:\/\/doi.org\/10.3389\/fphar.2021.755230","journal-title":"Front Pharmacol"},{"issue":"4","key":"1890_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00296-004-0564-8","volume":"25","author":"V Cobankara","year":"2005","unstructured":"Cobankara V et al (2005) Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis. Rheumatol Int 25(4):285\u2013291. https:\/\/doi.org\/10.1007\/s00296-004-0564-8","journal-title":"Rheumatol Int"},{"issue":"3","key":"1890_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2249.2010.04270.x","volume":"162","author":"JS Coelho dos Santos","year":"2010","unstructured":"Coelho dos Santos JS et al (2010) Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells. Clin Exp Immunol 162(3):528\u2013536. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04270.x","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1890_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.7326\/M19-0675","volume":"172","author":"PG Conaghan","year":"2020","unstructured":"Conaghan PG et al (2020) Disease-modifying effects of a novel Cathepsin K inhibitor in osteoarthritis: a randomized controlled trial. Ann Intern Med 172(2):86\u201395. https:\/\/doi.org\/10.7326\/M19-0675","journal-title":"Ann Intern Med"},{"issue":"9","key":"1890_CR18","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","volume":"185","author":"KD Da Silveira","year":"2010","unstructured":"Da Silveira KD et al (2010) Anti-inflammatory effects of the activation of the angiotensin-(1\u20137) receptor, MAS, in experimental models of arthritis. J Immunol 185(9):5569\u20135576. https:\/\/doi.org\/10.4049\/jimmunol.1000314","journal-title":"J Immunol"},{"issue":"1","key":"1890_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/rheumatology\/keh398","volume":"44","author":"N Dalbeth","year":"2005","unstructured":"Dalbeth N et al (2005) The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis. Rheumatology (Oxford) 44(1):24\u201331. https:\/\/doi.org\/10.1093\/rheumatology\/keh398","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1890_CR20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/pds.3291","volume":"21","author":"HJ De Jong","year":"2012","unstructured":"De Jong HJ et al (2012) Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users. Pharmacoepidemiol Drug Saf 21(8):835\u2013843. https:\/\/doi.org\/10.1002\/pds.3291","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"1890_CR21","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/art.24844","volume":"60","author":"MJ Del Rey","year":"2009","unstructured":"Del Rey MJ et al (2009) Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia\u2010inducible transcription factor 1\u03b1\/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum 60(10):2926\u20132934. https:\/\/doi.org\/10.1002\/art.24844","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1890_CR22","doi-asserted-by":"publisher","first-page":"e023889","DOI":"10.1136\/bmjopen-2018-023889","volume":"8","author":"LA Deveza","year":"2018","unstructured":"Deveza LA et al (2018) Efficacy of bisphosphonates in specific knee osteoarthritis subpopulations: protocol for an OA trial bank systematic review and individual patient data meta-analysis. BMJ Open 8(12):e023889. https:\/\/doi.org\/10.1136\/bmjopen-2018-023889","journal-title":"BMJ Open"},{"issue":"6 Pt 2","key":"1890_CR23","first-page":"I4","volume":"77","author":"VJ Dzau","year":"1988","unstructured":"Dzau VJ (1988) Circulating versus local renin\u2013angiotensin system in cardiovascular homeostasis. Circulation 77(6 Pt 2):I4-13","journal-title":"Circulation"},{"issue":"1","key":"1890_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrrheum.2013.159","volume":"10","author":"CH Evans","year":"2014","unstructured":"Evans CH, Kraus VB, Setton LA (2014) Progress in intra-articular therapy. Nat Rev Rheumatol 10(1):11\u201322. https:\/\/doi.org\/10.1038\/nrrheum.2013.159","journal-title":"Nat Rev Rheumatol"},{"key":"1890_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejphar.2015.08.026","volume":"765","author":"MG Fahmy Wahba","year":"2015","unstructured":"Fahmy Wahba MG, Shehata Messiha BA, Abo-Saif AA (2015) Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats. Eur J Pharmacol 765:307\u2013315. https:\/\/doi.org\/10.1016\/j.ejphar.2015.08.026","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1890_CR26","first-page":"141","volume":"105","author":"LA Fernandez","year":"1985","unstructured":"Fernandez LA, Twickler J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105(2):141\u2013145","journal-title":"J Lab Clin Med"},{"issue":"7070","key":"1890_CR27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature04483","volume":"438","author":"N Ferrara","year":"2005","unstructured":"Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438(7070):967\u2013974. https:\/\/doi.org\/10.1038\/nature04483","journal-title":"Nature"},{"issue":"7","key":"1890_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1042\/CS20130400","volume":"126","author":"CM Ferrario","year":"2014","unstructured":"Ferrario CM et al (2014) An evolving story of angiotensin-II-forming pathways in rodents and humans. Clin Sci (Lond) 126(7):461\u2013469. https:\/\/doi.org\/10.1042\/CS20130400","journal-title":"Clin Sci (Lond)"},{"issue":"17","key":"1890_CR29","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.107.734384","volume":"117","author":"AJ Flammer","year":"2008","unstructured":"Flammer AJ et al (2008) Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation 117(17):2262\u20132269. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.734384","journal-title":"Circulation"},{"issue":"3","key":"1890_CR30","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","volume":"98","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ et al (2018) Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev 98(3):1627\u20131738. https:\/\/doi.org\/10.1152\/physrev.00038.2017","journal-title":"Physiol Rev"},{"issue":"5","key":"1890_CR31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/annrheumdis-2013-203954","volume":"74","author":"M Fransen","year":"2015","unstructured":"Fransen M et al (2015) Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis 74(5):851\u2013858. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203954","journal-title":"Ann Rheum Dis"},{"issue":"4298","key":"1890_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1126\/science.194311","volume":"197","author":"J Friedland","year":"1977","unstructured":"Friedland J, Setton C, Silverstein E (1977) Angiotensin converting enzyme: induction by steroids in rabbit alveolar macrophages in culture. Science 197(4298):64\u201365. https:\/\/doi.org\/10.1126\/science.194311","journal-title":"Science"},{"issue":"2","key":"1890_CR33","first-page":"593","volume":"32","author":"AG Gaafar","year":"2019","unstructured":"Gaafar AG et al (2019) Protective effects of vitamin D and losartan in complete Freund\u2019s adjuvant-induced arthritis in rats. Pak J Pharm Sci 32(2):593\u2013600","journal-title":"Pak J Pharm Sci"},{"issue":"3991","key":"1890_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1126\/science.173.3991.64","volume":"173","author":"D Ganten","year":"1971","unstructured":"Ganten D et al (1971) Angiotensin-forming enzyme in brain tissue. Science 173(3991):64\u201365. https:\/\/doi.org\/10.1126\/science.173.3991.64","journal-title":"Science"},{"key":"1890_CR35","doi-asserted-by":"publisher","first-page":"1280312","DOI":"10.3389\/fmed.2023.1280312","volume":"10","author":"VJ Gilvaz","year":"2023","unstructured":"Gilvaz VJ, Reginato AM (2023) Artificial intelligence in rheumatoid arthritis: potential applications and future implications. Front Med 10:1280312. https:\/\/doi.org\/10.3389\/fmed.2023.1280312","journal-title":"Front Med"},{"issue":"6","key":"1890_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.7326\/0003-4819-146-6-200703200-00005","volume":"146","author":"YP Goekoop-Ruiterman","year":"2007","unstructured":"Goekoop-Ruiterman YP et al (2007) Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 146(6):406\u2013415. https:\/\/doi.org\/10.7326\/0003-4819-146-6-200703200-00005","journal-title":"Ann Intern Med"},{"issue":"3","key":"1890_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/ard.49.3.172","volume":"49","author":"M Goto","year":"1990","unstructured":"Goto M et al (1990) Spontaneous release of angiotensin converting enzyme and interleukin 1 beta from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition. Ann Rheum Dis 49(3):172\u2013176. https:\/\/doi.org\/10.1136\/ard.49.3.172","journal-title":"Ann Rheum Dis"},{"key":"1890_CR38","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.22115.1","author":"S Gr\u00e4ssel","year":"2020","unstructured":"Gr\u00e4ssel S, Muschter D (2020) Recent advances in the treatment of osteoarthritis. F1000Res. https:\/\/doi.org\/10.12688\/f1000research.22115.1","journal-title":"F1000Res"},{"key":"1890_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.matbio.2018.05.008","volume":"71","author":"F Guilak","year":"2018","unstructured":"Guilak F et al (2018) Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol 71:40\u201350. https:\/\/doi.org\/10.1016\/j.matbio.2018.05.008","journal-title":"Matrix Biol"},{"issue":"10","key":"1890_CR40","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20070657","volume":"204","author":"TJ Guzik","year":"2007","unstructured":"Guzik TJ et al (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204(10):2449\u20132460. https:\/\/doi.org\/10.1084\/jem.20070657","journal-title":"J Exp Med"},{"issue":"3","key":"1890_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1677\/joe.0.1560543","volume":"156","author":"H Hagiwara","year":"1998","unstructured":"Hagiwara H et al (1998) Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol 156(3):543\u2013550. https:\/\/doi.org\/10.1677\/joe.0.1560543","journal-title":"J Endocrinol"},{"key":"1890_CR42","doi-asserted-by":"publisher","first-page":"174480691985880","DOI":"10.1177\/1744806919858801","volume":"15","author":"S Hameed","year":"2019","unstructured":"Hameed S (2019) Na(v)1.7 and Na(v)1.8: role in the pathophysiology of pain. Mol Pain 15:1744806919858801. https:\/\/doi.org\/10.1177\/1744806919858801","journal-title":"Mol Pain"},{"issue":"1","key":"1890_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2010.05.020","volume":"212","author":"C Han","year":"2010","unstructured":"Han C et al (2010) Angiotensin II induces C-reactive protein expression through ERK1\/2 and JNK signaling in human aortic endothelial cells. Atherosclerosis 212(1):206\u2013212. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.05.020","journal-title":"Atherosclerosis"},{"issue":"1","key":"1890_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1677\/joe.0.1520005","volume":"152","author":"R Hatton","year":"1997","unstructured":"Hatton R, Stimpel M, Chambers TJ (1997) Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 152(1):5\u201310. https:\/\/doi.org\/10.1677\/joe.0.1520005","journal-title":"J Endocrinol"},{"issue":"6","key":"1890_CR45","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/s1357-2725(02)00278-9","volume":"35","author":"IC Haznedaroglu","year":"2003","unstructured":"Haznedaroglu IC, Ozt\u00fcrk MA (2003) Towards the understanding of the local hematopoietic bone marrow renin\u2013angiotensin system. Int J Biochem Cell Biol 35(6):867\u2013880. https:\/\/doi.org\/10.1016\/s1357-2725(02)00278-9","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"1890_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaci.2015.10.023","volume":"137","author":"M Her","year":"2016","unstructured":"Her M, Kavanaugh A (2016) Alterations in immune function with biologic therapies for autoimmune disease. J Allergy Clin Immunol 137(1):19\u201327. https:\/\/doi.org\/10.1016\/j.jaci.2015.10.023","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1890_CR47","doi-asserted-by":"publisher","first-page":"rkaa005","DOI":"10.1093\/rap\/rkaa005","volume":"4","author":"M H\u00fcgle","year":"2020","unstructured":"H\u00fcgle M et al (2020) Applied machine learning and artificial intelligence in rheumatology. Rheumatol Adv Pract 4(1):rkaa005. https:\/\/doi.org\/10.1093\/rap\/rkaa005","journal-title":"Rheumatol Adv Pract"},{"issue":"5","key":"1890_CR48","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.semnephrol.2007.07.005","volume":"27","author":"A Ichihara","year":"2007","unstructured":"Ichihara A et al (2007) The (pro)renin receptor and the kidney. Semin Nephrol 27(5):524\u2013528. https:\/\/doi.org\/10.1016\/j.semnephrol.2007.07.005","journal-title":"Semin Nephrol"},{"issue":"3","key":"1890_CR49","first-page":"306","volume":"22","author":"A Ichihara","year":"2009","unstructured":"Ichihara A et al (2009) Renin, prorenin and the kidney: a new chapter in an old saga. J Nephrol 22(3):306\u2013311","journal-title":"J Nephrol"},{"issue":"7","key":"1890_CR50","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"M Iwai","year":"2009","unstructured":"Iwai M, Horiuchi M (2009) Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1\u20137)-Mas receptor axis. Hypertens Res 32(7):533\u2013536. https:\/\/doi.org\/10.1038\/hr.2009.74","journal-title":"Hypertens Res"},{"issue":"4","key":"1890_CR51","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1681\/ASN.2006070707","volume":"18","author":"M Jurewicz","year":"2007","unstructured":"Jurewicz M et al (2007) Human T and natural killer cells possess a functional renin\u2013angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol 18(4):1093\u20131102. https:\/\/doi.org\/10.1681\/ASN.2006070707","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"1890_CR52","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.joca.2016.07.017","volume":"24","author":"MA Karsdal","year":"2016","unstructured":"Karsdal MA et al (2016) Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future. Osteoarthr Cartilage 24(12):2013\u20132021. https:\/\/doi.org\/10.1016\/j.joca.2016.07.017","journal-title":"Osteoarthr Cartilage"},{"key":"1890_CR53","doi-asserted-by":"publisher","first-page":"648537","DOI":"10.1155\/2012\/648537","volume":"2012","author":"Y Kawakami","year":"2012","unstructured":"Kawakami Y et al (2012) Expression of angiotensin II receptor-1 in human articular chondrocytes. Arthritis 2012:648537. https:\/\/doi.org\/10.1155\/2012\/648537","journal-title":"Arthritis"},{"issue":"1","key":"1890_CR54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1189\/jlb.1204715","volume":"78","author":"MP Kim","year":"2005","unstructured":"Kim MP, Zhou M, Wahl LM (2005) Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture. J Leukoc Biol 78(1):195\u2013201. https:\/\/doi.org\/10.1189\/jlb.1204715","journal-title":"J Leukoc Biol"},{"issue":"3","key":"1890_CR55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/pr.59.3.3","volume":"59","author":"H Kobori","year":"2007","unstructured":"Kobori H et al (2007) The intrarenal renin\u2013angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59(3):251\u2013287. https:\/\/doi.org\/10.1124\/pr.59.3.3","journal-title":"Pharmacol Rev"},{"issue":"5","key":"1890_CR56","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1186\/ar2315","volume":"9","author":"P Krzeski","year":"2007","unstructured":"Krzeski P et al (2007) Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis Res Ther 9(5):R109. https:\/\/doi.org\/10.1186\/ar2315","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1890_CR57","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00125-003-1295-1","volume":"47","author":"T Lau","year":"2004","unstructured":"Lau T, Carlsson PO, Leung PS (2004) Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47(2):240\u2013248. https:\/\/doi.org\/10.1007\/s00125-003-1295-1","journal-title":"Diabetologia"},{"issue":"6","key":"1890_CR58","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1210\/en.2003-0150","volume":"144","author":"JL Lavoie","year":"2003","unstructured":"Lavoie JL, Sigmund CD (2003) Minireview: overview of the renin\u2013angiotensin system\u2014an endocrine and paracrine system. Endocrinology 144(6):2179\u20132183. https:\/\/doi.org\/10.1210\/en.2003-0150","journal-title":"Endocrinology"},{"issue":"3","key":"1890_CR59","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1559-4564.2006.05460.x","volume":"1","author":"PS Leung","year":"2006","unstructured":"Leung PS, de Gasparo M (2006) Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome. J Cardiometab Syndr 1(3):197\u2013203. https:\/\/doi.org\/10.1111\/j.1559-4564.2006.05460.x","journal-title":"J Cardiometab Syndr"},{"issue":"1","key":"1890_CR60","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12967-018-1425-7","volume":"16","author":"E Lindstr\u00f6m","year":"2018","unstructured":"Lindstr\u00f6m E et al (2018) The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis. J Transl Med 16(1):56. https:\/\/doi.org\/10.1186\/s12967-018-1425-7","journal-title":"J Transl Med"},{"key":"1890_CR61","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.2147\/TCRM.S174693","volume":"14","author":"NMA Mahmood","year":"2018","unstructured":"Mahmood NMA, Hussain SA, Mirza RR (2018) Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study. Ther Clin Risk Manag 14:1379\u20131385. https:\/\/doi.org\/10.2147\/TCRM.S174693","journal-title":"Ther Clin Risk Manag"},{"key":"1890_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.actbio.2018.12.006","volume":"85","author":"Y Mao","year":"2019","unstructured":"Mao Y et al (2019) Extracellular matrix derived from chondrocytes promotes rapid expansion of human primary chondrocytes in vitro with reduced dedifferentiation. Acta Biomater 85:75\u201383. https:\/\/doi.org\/10.1016\/j.actbio.2018.12.006","journal-title":"Acta Biomater"},{"issue":"8390","key":"1890_CR63","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/s0140-6736(84)91821-x","volume":"1","author":"MF Martin","year":"1984","unstructured":"Martin MF et al (1984) Captopril: a new treatment for rheumatoid arthritis? Lancet 1(8390):1325\u20131328. https:\/\/doi.org\/10.1016\/s0140-6736(84)91821-x","journal-title":"Lancet"},{"issue":"2","key":"1890_CR64","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semarthrit.2014.05.001","volume":"44","author":"F Matcham","year":"2014","unstructured":"Matcham F et al (2014) The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum 44(2):123\u2013130. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.001","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"1890_CR65","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1161\/01.HYP.0000140269.55873.7b","volume":"44","author":"L Mazzolai","year":"2004","unstructured":"Mazzolai L et al (2004) Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE\u2212\/\u2212 mice. Hypertension 44(3):277\u2013282. https:\/\/doi.org\/10.1161\/01.HYP.0000140269.55873.7b","journal-title":"Hypertension"},{"issue":"1","key":"1890_CR111","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/art.41899","volume":"74","author":"A Mc Ardle","year":"2022","unstructured":"Mc Ardle A, Kwasnik A, Szentpetery A, Hernandez B, Parnell A, de Jager W, de Roock S, FitzGerald O, Pennington SR (2022) Identification and evaluation of serum protein biomarkers that differentiate psoriatic arthritis from rheumatoid arthritis. Arthritis & Rheumatol (Hoboken, N.J.) 74(1):81\u201391. https:\/\/doi.org\/10.1002\/art.41899","journal-title":"Arthritis & Rheumatol (Hoboken, N.J.)"},{"issue":"12","key":"1890_CR66","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11926-013-0385-4","volume":"15","author":"A Mobasheri","year":"2013","unstructured":"Mobasheri A (2013) The future of osteoarthritis therapeutics: emerging biological therapy. Curr Rheumatol Rep 15(12):385. https:\/\/doi.org\/10.1007\/s11926-013-0385-4","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"1890_CR67","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3904\/kjim.2010.25.4.429","volume":"25","author":"SJ Moon","year":"2010","unstructured":"Moon SJ et al (2010) Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts. Korean J Intern Med 25(4):429\u2013435. https:\/\/doi.org\/10.3904\/kjim.2010.25.4.429","journal-title":"Korean J Intern Med"},{"key":"1890_CR68","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.freeradbiomed.2013.08.183","volume":"65","author":"ED Moore","year":"2013","unstructured":"Moore ED et al (2013) Angiotensin-(1\u20137) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling. Free Radic Biol Med 65:1060\u20131068. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.08.183","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"1890_CR69","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4103\/ijmr.IJMR_640_19","volume":"152","author":"TM Mostafa","year":"2020","unstructured":"Mostafa TM et al (2020) A comparative study on the anti-inflammatory effect of angiotensin-receptor blockers & statins on rheumatoid arthritis disease activity. Indian J Med Res 152(4):393\u2013400. https:\/\/doi.org\/10.4103\/ijmr.IJMR_640_19","journal-title":"Indian J Med Res"},{"key":"1890_CR70","doi-asserted-by":"publisher","first-page":"1759720X2210762","DOI":"10.1177\/1759720X221076211","volume":"14","author":"J Mucke","year":"2022","unstructured":"Mucke J, Krusche M, Burmester GR (2022) A broad look into the future of rheumatoid arthritis. Ther Adv Musculoskelet Dis 14:1759720X221076211. https:\/\/doi.org\/10.1177\/1759720X221076211","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3","key":"1890_CR71","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1124\/jpet.109.161760","volume":"334","author":"K Nahmod","year":"2010","unstructured":"Nahmod K et al (2010) Impaired function of dendritic cells deficient in angiotensin II type 1 receptors. J Pharmacol Exp Ther 334(3):854\u2013862. https:\/\/doi.org\/10.1124\/jpet.109.161760","journal-title":"J Pharmacol Exp Ther"},{"key":"1890_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd6020014","author":"A Nehme","year":"2019","unstructured":"Nehme A et al (2019) An update on the tissue renin angiotensin system and its role in physiology and pathology. J Cardiovasc Dev Dis. https:\/\/doi.org\/10.3390\/jcdd6020014","journal-title":"J Cardiovasc Dev Dis"},{"issue":"11","key":"1890_CR73","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/JCI14276","volume":"109","author":"G Nguyen","year":"2002","unstructured":"Nguyen G et al (2002) Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Investig 109(11):1417\u20131427. https:\/\/doi.org\/10.1172\/JCI14276","journal-title":"J Clin Investig"},{"issue":"11","key":"1890_CR74","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1161\/01.ATV.0000145607.03879.e0","volume":"24","author":"A Nobuhiko","year":"2004","unstructured":"Nobuhiko A et al (2004) Angiotensin II amplifies macrophage-driven atherosclerosis. Arterioscler Thromb Vasc Biol 24(11):2143\u20132148. https:\/\/doi.org\/10.1161\/01.ATV.0000145607.03879.e0","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1890_CR75","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1365-2249.2000.01323.x","volume":"121","author":"C Odaka","year":"2000","unstructured":"Odaka C, Mizuochi T (2000) Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals. Clin Exp Immunol 121(3):515\u2013522. https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01323.x","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"1890_CR76","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1248\/bpb.33.1517","volume":"33","author":"M Okada","year":"2010","unstructured":"Okada M et al (2010) Effects of captopril and telmisartan on matrix metalloproteinase-2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats. Biol Pharm Bull 33(9):1517\u20131521. https:\/\/doi.org\/10.1248\/bpb.33.1517","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"1890_CR77","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1152\/physrev.00036.2005","volume":"86","author":"M Paul","year":"2006","unstructured":"Paul M, PoyanMehr A, Kreutz R (2006) Physiology of local renin\u2013angiotensin systems. Physiol Rev 86(3):747\u2013803. https:\/\/doi.org\/10.1152\/physrev.00036.2005","journal-title":"Physiol Rev"},{"issue":"2","key":"1890_CR78","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","volume":"17","author":"M Paz Ocaranza","year":"2020","unstructured":"Paz Ocaranza M et al (2020) Counter-regulatory renin\u2013angiotensin system in cardiovascular disease. Nat Rev Cardiol 17(2):116\u2013129. https:\/\/doi.org\/10.1038\/s41569-019-0244-8","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"1890_CR79","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1136\/ard.2007.082917","volume":"67","author":"ME Perry","year":"2008","unstructured":"Perry ME et al (2008) Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis. Ann Rheum Dis 67(11):1646\u20131647. https:\/\/doi.org\/10.1136\/ard.2007.082917","journal-title":"Ann Rheum Dis"},{"issue":"1\u20133","key":"1890_CR80","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ejphar.2012.10.024","volume":"698","author":"R Refaat","year":"2013","unstructured":"Refaat R et al (2013) Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats. Eur J Pharmacol 698(1\u20133):421\u2013428. https:\/\/doi.org\/10.1016\/j.ejphar.2012.10.024","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1890_CR81","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/annrheumdis-2012-202231","volume":"72","author":"JY Reginster","year":"2013","unstructured":"Reginster JY et al (2013) Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis 72(2):179\u2013186. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202231","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1890_CR82","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","volume":"18","author":"TR Rodrigues Prestes","year":"2017","unstructured":"Rodrigues Prestes TR et al (2017) The anti-inflammatory potential of ACE2\/angiotensin-(1\u20137)\/Mas receptor axis: evidence from basic and clinical research. Curr Drug Targets 18(11):1301\u20131313. https:\/\/doi.org\/10.2174\/1389450117666160727142401","journal-title":"Curr Drug Targets"},{"issue":"15","key":"1890_CR83","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1517\/14656566.2013.825606","volume":"14","author":"C Roubille","year":"2013","unstructured":"Roubille C, Pelletier JP, Martel-Pelletier J (2013) New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine? Expert Opin Pharmacother 14(15):2059\u20132077. https:\/\/doi.org\/10.1517\/14656566.2013.825606","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"1890_CR84","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/art.21040","volume":"52","author":"K Sagawa","year":"2005","unstructured":"Sagawa K et al (2005) Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice. Arthritis Rheum 52(6):1920\u20131928. https:\/\/doi.org\/10.1002\/art.21040","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1890_CR85","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/art.27384","volume":"62","author":"T Sakuta","year":"2010","unstructured":"Sakuta T et al (2010) Involvement of the renin\u2013angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers. Arthritis Rheum 62(5):1319\u20131328. https:\/\/doi.org\/10.1002\/art.27384","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1890_CR86","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bph.13063","volume":"173","author":"AK Sampson","year":"2016","unstructured":"Sampson AK et al (2016) Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo. Br J Pharmacol 173(4):729\u2013740. https:\/\/doi.org\/10.1111\/bph.13063","journal-title":"Br J Pharmacol"},{"issue":"12","key":"1890_CR87","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11906-018-0900-0","volume":"20","author":"R Satou","year":"2018","unstructured":"Satou R, Penrose H, Navar LG (2018) Inflammation as a regulator of the renin-angiotensin system and blood pressure. Curr Hypertens Rep 20(12):100. https:\/\/doi.org\/10.1007\/s11906-018-0900-0","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"1890_CR88","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.ijo.0800821","volume":"23","author":"P Schling","year":"1999","unstructured":"Schling P et al (1999) Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord 23(4):336\u2013341. https:\/\/doi.org\/10.1038\/sj.ijo.0800821","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"1890_CR89","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1152\/ajpendo.00158.2020","volume":"320","author":"NN Sha","year":"2021","unstructured":"Sha NN et al (2021) Differential responses of bone to angiotensin II and angiotensin(1\u20137): beneficial effects of ANG(1\u20137) on bone with exposure to high glucose. Am J Physiol Endocrinol Metab 320(1):E55\u2013E70. https:\/\/doi.org\/10.1152\/ajpendo.00158.2020","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"22","key":"1890_CR90","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.26355\/eurrev_201811_16429","volume":"22","author":"ZJ Shen","year":"2018","unstructured":"Shen ZJ et al (2018) Telmisartan inhibits Ang II-induced MMP-9 expression in macrophages in stabilizing atheromatous plaque. Eur Rev Med Pharmacol Sci 22(22):8004\u20138012. https:\/\/doi.org\/10.26355\/eurrev_201811_16429","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1890_CR91","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.peptides.2013.05.012","volume":"46","author":"KD Silveira","year":"2013","unstructured":"Silveira KD et al (2013) Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis. Peptides 46:53\u201363. https:\/\/doi.org\/10.1016\/j.peptides.2013.05.012","journal-title":"Peptides"},{"issue":"8","key":"1890_CR92","first-page":"12584","volume":"8","author":"Y Tang","year":"2015","unstructured":"Tang Y, Hu X, Lu X (2015) Captopril, an angiotensin-converting enzyme inhibitor, possesses chondroprotective efficacy in a rat model of osteoarthritis through suppression local renin\u2013angiotensin system. Int J Clin Exp Med 8(8):12584\u201312592","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"1890_CR93","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/art.41516","volume":"73","author":"W Tao","year":"2021","unstructured":"Tao W et al (2021) Multiomics and machine learning accurately predict clinical response to Adalimumab and Etanercept therapy in patients with rheumatoid arthritis. Arthritis Rheumatol 73(2):212\u2013222. https:\/\/doi.org\/10.1002\/art.41516","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1890_CR94","doi-asserted-by":"publisher","first-page":"13293","DOI":"10.1038\/s41598-017-13746-w","volume":"7","author":"R Terenzi","year":"2017","unstructured":"Terenzi R et al (2017) Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium. Sci Rep 7(1):13293. https:\/\/doi.org\/10.1038\/s41598-017-13746-w","journal-title":"Sci Rep"},{"issue":"2","key":"1890_CR95","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.joca.2017.11.013","volume":"26","author":"EE Vaysbrot","year":"2018","unstructured":"Vaysbrot EE et al (2018) Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthr Cartil 26(2):154\u2013164. https:\/\/doi.org\/10.1016\/j.joca.2017.11.013","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"1890_CR96","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.0105-2896.2009.00857.x","volume":"233","author":"NC Walsh","year":"2010","unstructured":"Walsh NC, Gravallese EM (2010) Bone remodeling in rheumatic disease: a question of balance. Immunol Rev 233(1):301\u2013312. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00857.x","journal-title":"Immunol Rev"},{"issue":"2","key":"1890_CR97","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/ard.59.2.125","volume":"59","author":"DA Walsh","year":"2000","unstructured":"Walsh DA, Catravas J, Wharton J (2000) Angiotensin converting enzyme in human synovium: increased stromal [(125)I]351A binding in rheumatoid arthritis. Ann Rheum Dis 59(2):125\u2013131. https:\/\/doi.org\/10.1136\/ard.59.2.125","journal-title":"Ann Rheum Dis"},{"key":"1890_CR98","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.intimp.2018.11.001","volume":"65","author":"Y Wang","year":"2018","unstructured":"Wang Y et al (2018) The renin\u2013angiotensin system in the synovium promotes periarticular osteopenia in a rat model of collagen-induced arthritis. Int Immunopharmacol 65:550\u2013558. https:\/\/doi.org\/10.1016\/j.intimp.2018.11.001","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1890_CR99","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10787-018-0545-2","volume":"27","author":"X Wang","year":"2019","unstructured":"Wang X et al (2019) Losartan suppresses the inflammatory response in collagen-induced arthritis by inhibiting the MAPK and NF-\u03baB pathways in B and T cells. Inflammopharmacology 27(3):487\u2013502. https:\/\/doi.org\/10.1007\/s10787-018-0545-2","journal-title":"Inflammopharmacology"},{"issue":"2","key":"1890_CR100","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2478\/rir-2023-0011","volume":"4","author":"J Wang","year":"2023","unstructured":"Wang J, Tian Y, Zhou T, Tong D, Ma J, Li J (2023) A survey of artificial intelligence in rheumatoid arthritis. Rheumatol Immunol Res 4(2):69\u201377. https:\/\/doi.org\/10.2478\/rir-2023-0011","journal-title":"Rheumatol Immunol Res"},{"issue":"4","key":"1890_CR101","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1161\/01.RES.0000115557.25127.8D","volume":"94","author":"S Wassmann","year":"2004","unstructured":"Wassmann S et al (2004) Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94(4):534\u2013541. https:\/\/doi.org\/10.1161\/01.RES.0000115557.25127.8D","journal-title":"Circ Res"},{"issue":"3","key":"1890_CR102","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","volume":"47","author":"JA Wessels","year":"2008","unstructured":"Wessels JA, Huizinga TW, Guchelaar HJ (2008) Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 47(3):249\u2013255. https:\/\/doi.org\/10.1093\/rheumatology\/kem279","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1890_CR103","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/01.hyp.25.5.913","volume":"25","author":"B Williams","year":"1995","unstructured":"Williams B et al (1995) Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 25(5):913\u2013917. https:\/\/doi.org\/10.1161\/01.hyp.25.5.913","journal-title":"Hypertension"},{"issue":"1","key":"1890_CR104","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.amjms.2019.10.014","volume":"359","author":"Y Wu","year":"2020","unstructured":"Wu Y et al (2020) Differential expression of renin\u2013angiotensin system-related components in patients with rheumatoid arthritis and osteoarthritis. Am J Med Sci 359(1):17\u201326. https:\/\/doi.org\/10.1016\/j.amjms.2019.10.014","journal-title":"Am J Med Sci"},{"issue":"1","key":"1890_CR105","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/nyas.13000","volume":"1376","author":"L Xie","year":"2016","unstructured":"Xie L et al (2016) Systemic neutralization of TGF-\u03b2 attenuates osteoarthritis. Ann N Y Acad Sci 1376(1):53\u201364. https:\/\/doi.org\/10.1111\/nyas.13000","journal-title":"Ann N Y Acad Sci"},{"key":"1890_CR106","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ijcard.2015.03.059","volume":"184","author":"J Yang","year":"2015","unstructured":"Yang J et al (2015) Endogenous activated angiotensin-(1\u20137) plays a protective effect against atherosclerotic plaques unstability in high fat diet fed ApoE knockout mice. Int J Cardiol 184:645\u2013652. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.059","journal-title":"Int J Cardiol"},{"issue":"5","key":"1890_CR107","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1080\/14397595.2020.1782049","volume":"30","author":"T Yoshiya","year":"2020","unstructured":"Yoshiya T (2020) A review of upadacitinib in rheumatoid arthritis. Mod Rheumatol 30(5):779\u2013787. https:\/\/doi.org\/10.1080\/14397595.2020.1782049","journal-title":"Mod Rheumatol"},{"key":"1890_CR108","doi-asserted-by":"publisher","first-page":"105703","DOI":"10.1016\/j.biocel.2020.105703","volume":"121","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020) Angiotensin II inhibits osteogenic differentiation of isolated synoviocytes by increasing DKK-1 expression. Int J Biochem Cell Biol 121:105703. https:\/\/doi.org\/10.1016\/j.biocel.2020.105703","journal-title":"Int J Biochem Cell Biol"},{"issue":"17","key":"1890_CR109","doi-asserted-by":"publisher","first-page":"11756","DOI":"10.1021\/acsomega.1c01170","volume":"6","author":"X Zhang","year":"2021","unstructured":"Zhang X et al (2021) Telmisartan mitigates TNF-\u03b1-induced type II collagen reduction by upregulating SOX-9. ACS Omega 6(17):11756\u201311761. https:\/\/doi.org\/10.1021\/acsomega.1c01170","journal-title":"ACS Omega"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01890-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01890-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01890-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:13:48Z","timestamp":1758082428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01890-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":111,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1890"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01890-z","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agree, and on behalf of them, the corresponding author is submitting the research paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}